PRECLINICAL STUDY
The Role of Platelet-Derived Growth Factor Signaling in Healing Myocardial Infarcts
Pawel Zymek, MD*,
Marcin Bujak, MD*,
Khaled Chatila, MD*,
Anna Cieslak, MS*,
Geeta Thakker, PhD ,
Mark L. Entman, MD, FACC* and
Nikolaos G. Frangogiannis, MD, FACC*,*
* Section of Cardiovascular Sciences, the DeBakey Heart Center, Baylor College of Medicine, and the Methodist Hospital, Houston, Texas
Section of Atherosclerosis, the DeBakey Heart Center, Baylor College of Medicine, and the Methodist Hospital, Houston, Texas.
Manuscript received June 1, 2006;
revised manuscript received July 13, 2006,
accepted July 17, 2006.
* Reprint requests and correspondence: Dr. Nikolaos G. Frangogiannis, Section of Cardiovascular Sciences, One Baylor Plaza, M/S F-602, Baylor College of Medicine, Houston, Texas 77030. (Email: ngf{at}bcm.tmc.edu).
OBJECTIVES: This study sought to examine the role of platelet-derived growth factor (PDGF) signaling in healing myocardial infarcts.
BACKGROUND: Platelet-derived growth factor isoforms exert potent fibrogenic effects through interactions with PDGF receptor (PDGFR)- and PDGFR-ß. In addition, PDGFR-ß signaling mediates coating of developing vessels with mural cells, leading to the formation of a mature vasculature. We hypothesized that PDGFR activation may regulate fibrosis and vascular maturation in healing myocardial infarcts.
METHODS: Mice undergoing reperfused infarction protocols were injected daily with a neutralizing anti–PDGFR-ß antibody (APB5), an anti-PDGFR- antibody (APA5), or control immunoglobulin G, and were killed after 7 days of reperfusion.
RESULTS: The PDGF-B, PDGFR-, and PDGFR-ß mRNA expression was induced in reperfused mouse infarcts. Perivascular cells expressing phosphorylated PDGFR-ß were identified in the infarct after 7 days of reperfusion, indicating activation of the PDGF-BB/PDGFR-ß pathway. The PDGFR-ß blockade resulted in impaired maturation of the infarct vasculature, enhanced capillary density, and formation of dilated uncoated vessels. Defective vascular maturation in antibody-treated mice was associated with increased and prolonged extravasation of red blood cells and monocyte/macrophages, suggesting increased permeability. These defects resulted in decreased collagen content in the healing infarct. In contrast, PDGFR- inhibition did not affect vascular maturation, but significantly decreased collagen deposition in the infarct.
CONCLUSIONS: Platelet-derived growth factor signaling critically regulates postinfarction repair. Both PDGFR-ß– and PDGFR-–mediated pathways promote collagen deposition in the infarct. Activation of PDGF-B/PDGFR-ß is also involved in recruitment of mural cells by neovessels, regulating maturation of the infarct vasculature. Acquisition of a mural coat and maturation of the vasculature promotes resolution of inflammation and stabilization of the scar.
|
Abbreviations and Acronyms
| | APA = anti–PDGFR- antibody | | APB = anti–PDGFR-ß antibody | | IgG = immunoglobulin G | | PCR = polymerase chain reaction | | PDGF = platelet-derived growth factor | | PDGFR = platelet-derived growth factor receptor | | SMA = smooth muscle actin |
|
This article has been cited by other articles:
|
|
|
|
 
N. G. Frangogiannis
Regulation of the Inflammatory Response in Cardiac Repair
Circ. Res.,
January 6, 2012;
110(1):
159 - 173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Katare, F. Riu, K. Mitchell, M. Gubernator, P. Campagnolo, Y. Cui, O. Fortunato, E. Avolio, D. Cesselli, A. P. Beltrami, et al.
Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132
Circ. Res.,
September 30, 2011;
109(8):
894 - 906.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. Osherov, L. Gotha, A. N. Cheema, B. Qiang, and B. H. Strauss
Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy
Cardiovasc Res,
July 1, 2011;
91(1):
16 - 26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Kupatt, R. Hinkel, A. Pfosser, C. El-Aouni, A. Wuchrer, A. Fritz, F. Globisch, M. Thormann, J. Horstkotte, C. Lebherz, et al.
Cotransfection of Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-B Via Recombinant Adeno-Associated Virus Resolves Chronic Ischemic Malperfusion: Role of Vessel Maturation
J. Am. Coll. Cardiol.,
July 27, 2010;
56(5):
414 - 422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Winter, A. A.M. van Oorschot, B. Hogers, L. M. van der Graaf, P. A. Doevendans, R. E. Poelmann, D. E. Atsma, A. C. Gittenberger-de Groot, and M. J. Goumans
A New Direction for Cardiac Regeneration Therapy: Application of Synergistically Acting Epicardium-Derived Cells and Cardiomyocyte Progenitor Cells
Circ Heart Fail,
November 1, 2009;
2(6):
643 - 653.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lange, J. Heger, G. Euler, M. Wartenberg, H. M. Piper, and H. Sauer
Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species
Cardiovasc Res,
January 1, 2009;
81(1):
159 - 168.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-X. Chen and A. Stinnett
Ang-1 Gene Therapy Inhibits Hypoxia-Inducible Factor-1{alpha} (HIF-1{alpha})-Prolyl-4-Hydroxylase-2, Stabilizes HIF-1{alpha} Expression, and Normalizes Immature Vasculature in db/db Mice
Diabetes,
December 1, 2008;
57(12):
3335 - 3343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-X. Chen and A. Stinnett
Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice
Arterioscler Thromb Vasc Biol,
September 1, 2008;
28(9):
1606 - 1613.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Andrae, R. Gallini, and C. Betsholtz
Role of platelet-derived growth factors in physiology and medicine
Genes & Dev.,
May 15, 2008;
22(10):
1276 - 1312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bujak, H. J. Kweon, K. Chatila, N. Li, G. Taffet, and N. G. Frangogiannis
Aging-Related Defects Are Associated With Adverse Cardiac Remodeling in a Mouse Model of Reperfused Myocardial Infarction
J. Am. Coll. Cardiol.,
April 8, 2008;
51(14):
1384 - 1392.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
